Investigators found data that showed certain factors contributed to reinfection with the hepatitis C virus after treatment with direct-acting antivirals in people who inject drugs.
In US patients aged 20 to 59 years with a history of injection drug use, data showed that the prevalence of previous or ongoing hepatitis B virus infection is 4 times higher than in the general population.
Italian investigators found data that showed bulevirtide combined with tenofovir disoproxil fumarate was found to be well tolerated in patients with hepatitis D virus-related cirrhosis.
Researchers report on use of the short-duration, pangenotypic, ribavirin-free regimen in adolescents with chronic HCV infection.
Researchers found data that suggest after hepatitis C virus clearance impairment of HCV-specific CD8+ T cells persists.
In Spain, researchers found data from a real-world cohort that showed that retreatment and a sustained viral response, depending upon treatment nonresponse and genotype, can be achieved with certain combinations of direct-acting antivirals.
Researchers in Australia found that treatment with direct acting antivirals for hepatitis C in the primary care setting is effective in treatment uptake in people who inject drugs, compared with referrals to hospital-based services.
Researchers found data that showed after liver transplantation in patients with hepatitis C virus, early acute cellular rejection is less common in the direct-acting antiviral era, with reduced mortality.
Researchers found data that showed in patients with hepatitis C, the presence of resistance-associated substitutions did not change the sustained viral response after treatment failure with other direct-acting-antivirals with the combination of sofosbuvir, velpatasvir, and voxilaprevir.
Researchers found data that showed in pregnant women with hepatitis B, the antiviral medications telbivudine and tenofovir disoproxil fumarate were safe, effective, and well tolerated, while reducing transmission of hepatitis B from mother to child during the perinatal period.
